share_log

Integer Holdings Co. (NYSE:ITGR) Shares Sold by JPMorgan Chase & Co.

Integer Holdings Co. (NYSE:ITGR) Shares Sold by JPMorgan Chase & Co.

摩根大通出售的Integer Holdings Co.股票。
Defense World ·  2022/09/06 04:32

JPMorgan Chase & Co. lowered its stake in shares of Integer Holdings Co. (NYSE:ITGR – Get Rating) by 5.9% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 236,567 shares of the medical equipment provider's stock after selling 14,765 shares during the quarter. JPMorgan Chase & Co.'s holdings in Integer were worth $19,060,000 at the end of the most recent quarter.

據HoldingsChannel.com報道,摩根大通在第一季度減持了Integer Holdings Co.(紐約證券交易所代碼:ITGR-GET Rating)的股票5.9%。該機構投資者在本季度出售了14,765股後,持有這家醫療設備提供商的236,567股股票。截至最近一個季度末,摩根大通持有的Integer股份價值19,060,000美元。

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Advisor Group Holdings Inc. raised its position in Integer by 25.0% in the fourth quarter. Advisor Group Holdings Inc. now owns 5,155 shares of the medical equipment provider's stock valued at $442,000 after purchasing an additional 1,031 shares during the period. American Century Companies Inc. raised its position in Integer by 24.0% in the fourth quarter. American Century Companies Inc. now owns 4,610 shares of the medical equipment provider's stock valued at $395,000 after purchasing an additional 893 shares during the period. abrdn plc raised its position in Integer by 10.3% in the fourth quarter. abrdn plc now owns 790,246 shares of the medical equipment provider's stock valued at $67,637,000 after purchasing an additional 73,531 shares during the period. ProShare Advisors LLC raised its position in Integer by 61.6% in the fourth quarter. ProShare Advisors LLC now owns 8,177 shares of the medical equipment provider's stock valued at $701,000 after purchasing an additional 3,118 shares during the period. Finally, First Trust Advisors LP raised its position in Integer by 2.8% in the fourth quarter. First Trust Advisors LP now owns 16,664 shares of the medical equipment provider's stock valued at $1,426,000 after purchasing an additional 460 shares during the period. Institutional investors and hedge funds own 99.26% of the company's stock.

其他機構投資者和對衝基金最近也增持或減持了該公司的股份。Advisor Group Holdings Inc.在第四季度將其在Integer的頭寸提高了25.0%。Advisor Group Holdings Inc.在此期間又購買了1,031股,現在擁有這家醫療設備提供商的5,155股股票,價值442,000美元。美國世紀公司第四季度將其在Integer的持倉提高了24.0%。美國世紀公司目前持有這家醫療設備提供商的4,610股股票,價值39.5萬美元,在此期間又購買了893股。Abrdn plc在第四季度將其在Integer的頭寸提高了10.3%。在此期間,ABRDN plc又購買了73,531股,目前持有這家醫療設備提供商790,246股股票,價值67,637,000美元。ProShare Advisors LLC在第四季度將其在Integer的頭寸提高了61.6%。在此期間,ProShare Advisors LLC又購買了3,118股,現在擁有這家醫療設備提供商8,177股股票,價值701,000美元。最後,First Trust Advisors LP在第四季度將其在Integer的頭寸提高了2.8%。First Trust Advisors LP現在擁有這家醫療設備提供商16,664股股票,價值1,426,000美元,在此期間又購買了460股。機構投資者和對衝基金持有該公司99.26%的股票。

Get
到達
Integer
整型
alerts:
警報:

Insiders Place Their Bets

內部人士下注

In other Integer news, insider Carter Houghton sold 2,708 shares of the company's stock in a transaction dated Friday, August 12th. The stock was sold at an average price of $74.13, for a total transaction of $200,744.04. Following the sale, the insider now owns 3,262 shares in the company, valued at approximately $241,812.06. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 2.01% of the stock is owned by company insiders.

在Integer的其他消息中,內部人士卡特·霍頓在一筆日期為8月12日星期五的交易中出售了2708股該公司股票。該股以74.13美元的平均價格出售,總成交金額為200,744.04美元。出售後,這位內部人士現在擁有該公司3262股,價值約241,812.06美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可通過美國證券交易委員會網站獲得。2.01%的股份由公司內部人士持有。

Wall Street Analysts Forecast Growth

華爾街分析師預測經濟增長

ITGR has been the topic of a number of research analyst reports. TheStreet downgraded Integer from a "b-" rating to a "c+" rating in a research report on Friday, May 13th. KeyCorp cut their price objective on Integer from $109.00 to $97.00 and set an "overweight" rating on the stock in a report on Friday, July 29th.
ITGR已經成為許多研究分析師報告的主題。華爾街在5月13日星期五的一份研究報告中將Integer的評級從“b-”下調至“c+”。KeyCorp在7月29日星期五的一份報告中將Integer的目標價從109.00美元下調至97美元,並對該股設定了“增持”評級。

Integer Price Performance

整體性價比

ITGR stock opened at $60.67 on Tuesday. The company has a current ratio of 2.70, a quick ratio of 1.71 and a debt-to-equity ratio of 0.68. The company has a market capitalization of $2.01 billion, a PE ratio of 26.04 and a beta of 1.23. Integer Holdings Co. has a 12-month low of $60.08 and a 12-month high of $99.92. The business's fifty day moving average price is $69.83 and its 200 day moving average price is $75.43.

週二,ITGR股價開盤報60.67美元。該公司的流動比率為2.70,速動比率為1.71,債務權益比率為0.68。該公司市值20.1億美元,市盈率為26.04倍,貝塔係數為1.23。Integer Holdings Co.股價跌至60.08美元的12個月低點,以及99.92美元的12個月高點。該業務的50日移動均線價格為69.83美元,200日移動均線價格為75.43美元。

Integer (NYSE:ITGR – Get Rating) last issued its quarterly earnings results on Thursday, July 28th. The medical equipment provider reported $1.04 earnings per share for the quarter, missing the consensus estimate of $1.18 by ($0.14). Integer had a return on equity of 9.50% and a net margin of 6.10%. The company had revenue of $350.10 million for the quarter, compared to analysts' expectations of $343.57 million. During the same quarter last year, the company earned $1.07 EPS. Integer's revenue for the quarter was up 12.2% compared to the same quarter last year. On average, sell-side analysts anticipate that Integer Holdings Co. will post 4.3 EPS for the current year.

Integer(NYSE:ITGR-GET Rating)上一次發佈季度收益報告是在7月28日(星期四)。這家醫療設備提供商公佈本季度每股收益為1.04美元,低於普遍預期的1.18美元(0.14美元)。Integer的股本回報率為9.50%,淨利潤率為6.10%。該公司當季營收為3.501億美元,高於分析師預期的3.4357億美元。去年同期,該公司每股收益為1.07美元。與去年同期相比,Integer本季度的收入增長了12.2%。賣方分析師平均預計,Integer Holdings Co.本年度每股收益為4.3歐元。

Integer Profile

整型配置文件

(Get Rating)

(獲取評級)

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures.

INTEGER控股公司作為一家醫療設備外包製造商在美國、波多黎各、哥斯達黎加和國際上運營。它通過醫療和非醫療部門開展業務。該公司提供介入性心臟病學、結構性心臟、心力衰竭、外周血管、神經血管、介入性腫瘤學、電生理學、血管通路、輸液療法、血液透析、泌尿學和胃腸病學程序的產品。

Featured Articles

專題文章

  • Get a free copy of the StockNews.com research report on Integer (ITGR)
  • MarketBeat Podcast: Stock Market, Bad News is Good News
  • Forget Bitcoin, Block's Ecosystems are the Real Growth Drivers
  • What Does an Inverted Yield Curve Mean For You?
  • SPY vs. QQQ: Which ETF Wins in 2022?
  • Could Snap Stock Rebound As Management Restructures?
  • 免費獲取StockNews.com關於Integer(ITGR)的研究報告
  • 市場Beat播客:股市,壞消息就是好消息
  • 忘掉比特幣吧,Block的生態系統才是真正的增長動力
  • 收益率曲線倒置對你意味着什麼?
  • 標普500ETF VS QQQ:2022年哪隻ETF勝出?
  • 隨着管理層重組,股市能否迅速反彈?

Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Co. (NYSE:ITGR – Get Rating).

想看看其他對衝基金持有哪些ITGR嗎?訪問HoldingsChannel.com獲取Integer Holdings Co.(紐約證券交易所代碼:ITGR-GET Rating)的最新13F文件和內幕交易信息。

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.

接收Integer Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Integer和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論